Yijun Zheng | Medicine | Best Researcher Award

Posted on by Forensic Scientist

Mr. Yijun Zheng | Medicine | Best Researcher Award

The Second Hospital & Clinical Medical School, Lanzhou University | China

Dr. Zheng Yijun is a dedicated medical researcher currently pursuing a PhD in Surgery at Lanzhou University. With a strong focus on the pharmacological actions of traditional Chinese medicine in cancer treatment, particularly gastric cancer, he has contributed to multiple papers, including two independent SCI publications. Dr. Zheng also serves as a reviewer for high-impact journals like Frontiers in Medicine and International Journal of Clinical Practice. He is actively involved in projects funded by the National Natural Science Foundation of China and collaborates on key provincial research initiatives.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Research Focus: Zheng has a clear focus on the prevention and treatment of gastric cancer through traditional Chinese medicine, a significant and relevant area of study in modern healthcare.

  • Academic Contributions: Zheng has independently authored two SCI papers, one of which has achieved a high citation rate, highlighting the impact of their work in the academic community.

  • Collaborative Research: Zheng has been involved in eight research projects, including two funded by the National Natural Science Foundation of China, which demonstrates involvement in high-impact research.

  • Peer Review Contributions: Serving as a reviewer for reputable journals such as SCI and Frontiers in Medicine showcases the recognition of Zheng’s expertise and their ability to contribute to the broader academic community.

  • Zheng Yijun demonstrates strong academic research in a promising and highly relevant field. With a focus on traditional Chinese medicine for cancer treatment, significant publications, and involvement in prestigious research projects, Zheng is well-positioned for consideration for the “Best Researcher Award.” However, expanding the breadth of their research network, increasing publication output, and gaining editorial experience would help to further solidify their candidacy for this award.

Education 🎓

Dr. Zheng is currently enrolled in the PhD program in Surgery at Lanzhou University. His academic journey is complemented by his extensive participation in research, including a review of Astragalus Polysaccharide’s pharmacological effects, published in Frontiers in Pharmacology. He has independently authored SCI papers that contribute to the field of traditional medicine’s role in cancer treatment.

Experience 💼

Dr. Zheng has participated in over eight research projects, two of which were funded by the National Natural Science Foundation of China. His work spans across the investigation of gastric cancer treatment and the pharmacological effects of traditional Chinese medicine. Additionally, Dr. Zheng has served as a reviewer for multiple high-impact journals, solidifying his expertise and credibility in the field.

Research Interest On Medicine 🔬

Dr. Zheng’s primary research interest is in the prevention and treatment of gastric cancer through traditional Chinese medicine. His research aims to provide a theoretical foundation for incorporating traditional medicine in cancer therapy, with a specific focus on polysaccharides and their pharmacological actions in tumor treatment.

Award 🏆

Dr. Zheng is a nominee for the Best Researcher Award at the Forensic Scientist Awards, due to his significant contributions to the field of medical research, particularly in the application of traditional Chinese medicine for tumor treatment. His innovative work and high citation rate highlight his impact in medical research.

Publications 📚

  1. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. “A Review of the Pharmacological Action of Astragalus Polysaccharide.” Front Pharmacol. 2020 Mar 24; 11:349. Link

    • Cited by: 348 articles (SCI citation)

  2. Zheng Y, Zhang Y, Wang Z, Guo X, Zhang L, Zhang Y. “Multiple data sets to explore the key molecules and mechanism of lymph node metastasis in gastric cancer.” Discov Oncol. 2025 Apr 24; 16(1):606. Link

    • Cited by: 98 articles (SCI citation)

Conclusion 🌍

Dr. Zheng Yijun is an emerging leader in the field of medical research, particularly in the application of traditional Chinese medicine for cancer treatment. His dedication to advancing the understanding of gastric cancer and its treatment methods has already resulted in significant publications and recognition. As a nominee for the Best Researcher Award, his future in medical research looks promising, with continued contributions to the development of effective cancer therapies.

Mario Troisi | Medicine | Excellence in Innovation

Posted on by Forensic Scientist

Dr. Mario Troisi | Medicine | Excellence in Innovation

MD | University of Naples Federico II | Italy

Mario Troisi, MD, is an accomplished ophthalmologist and senior resident at the University of Naples Federico II, Italy. He graduated with distinction from the University of Salerno in Medicine and Surgery (110/110 cum laude). Dr. Troisi specializes in ocular surface diseases and corneal surgeries and has participated in numerous prestigious international fellowships, including a corneal fellowship at the University of Brescia and a cataract surgery program in Egypt. A prolific researcher and speaker, he has presented at over 30 national and international conferences. In 2024, Dr. Troisi received the ESCRS Trainee Bursary and the EVER Andrzej Grzybowski Award, highlighting his outstanding contributions to ophthalmology.

Profile

Orcid

Scopus

Google Scholar

Strengths for the Awards

  • Innovative Research Contributions:
    • Dr. Troisi has an impressive portfolio of peer-reviewed publications in high-impact journals. His work emphasizes cutting-edge methodologies like scanning electron microscopy (SEM) for ocular surface diseases, offering diagnostic and therapeutic innovations.
    • Topics such as ocular surface health biomarkers, keratitis diagnosis, and dry-eye treatment advancements showcase his forward-thinking research with potential for significant clinical impact.
  • Diverse Clinical Expertise:
    • His experience spans ophthalmology subspecialties, including cataract surgery, ocular surface diseases, and advanced imaging techniques like SD-OCT and fluorescein angiography.
    • He has engaged in multiple surgical fellowships and clinical trials, demonstrating hands-on application of his research.
  • Recognition and Awards:
    • Dr. Troisi has won prestigious accolades, such as the ESCRS Trainee Bursary and the Andrzej Grzybowski EVER Award in 2024. These reflect his contributions to ophthalmology and innovative research initiatives.
    • His active participation in international conferences as a speaker, presenter, and award finalist further highlights his ability to disseminate knowledge and inspire innovation.
  • Multidisciplinary Education:
    • His educational qualifications, including Master’s degrees in Aesthetic Medicine and Biostatistics, demonstrate a strong foundation in both clinical practice and statistical rigor—critical for conducting impactful research.

Education 🎓📚

Dr. Troisi’s academic journey began with a Scientific High School Diploma, achieved with honors in 2012. He earned his Master’s degree in Medicine and Surgery at the University of Salerno in 2019 (110/110 cum laude). His global outlook led him to an exchange program at Ivane Javakhishvili State University in Georgia. Furthering his expertise, he pursued residencies in ophthalmology, advanced surgical fellowships, and master’s degrees in aesthetic medicine (2023) and biostatistics for clinical research (2024). He also completed specialized training in ophthalmic echography and clinical cornea fellowships.

Professional Experience 💼

Since 2020, Dr. Troisi has worked as a medical practitioner across Salerno and Naples, Italy. His expertise spans internal medicine, ophthalmology, and emergency care. Notably, he contributed to local COVID-19 vaccination campaigns and gained hands-on surgical experience in cataract surgery, corneal cross-linking, and intravitreal injections. Currently, he is a senior resident at the University of Naples Federico II Eye Clinic, specializing in ocular surface diseases and advanced surgical interventions.

Research Interests On Medicine 🔬

Dr. Troisi is deeply involved in research on ocular surface diseases, corneal pathologies, and innovative ophthalmic treatments. His work utilizes advanced techniques such as scanning electron microscopy (SEM) to analyze conjunctival microvilli and evaluate new tear substitutes. His research focuses on clinical trials and translational medicine to improve patient outcomes in ophthalmology.

Awards and Recognitions 🏆🌟

Dr. Troisi has received multiple accolades for his contributions to ophthalmology. In 2024, he won the ESCRS Trainee Bursary and the EVER Andrzej Grzybowski Award. Additionally, his photography and research presentations have been recognized at international conferences, such as winning the “Eye Beyond the Surface” competition at the 27th EVER Congress.

Publications 📑📘

  • Comparative evaluation of antimicrobial, antiamoebic, and antiviral efficacy of ophthalmic formulations
    • Authors: C. Caruso, D. Eletto, A. Tosco, M. Pannetta, F. Scarinci, M. Troisi, A. Porta
    • Year: 2022
    • Citations: 12
  • Ocular surface infection by SARS-CoV-2 in COVID-19 pneumonia patients admitted to sub-intensive unit: preliminary results
    • Authors: M. Troisi, C. Zannella, S. Troisi, M. De Bernardo, M. Galdiero, G. Franci, …
    • Year: 2022
    • Citations: 12
  • Tear liquid for predictive diagnosis of Alzheimer’s disease
    • Authors: S. Del Prete, D. Marasco, R. Sabetta, A. Del Prete, F. Z. Marino, R. Franco, …
    • Year: 2021
    • Citations: 10
  • Scanning Electron Microscopy of Conjunctival Scraping: Our Experience in the Diagnosis of Infectious Keratitis with Negative Culture Tests
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, C. Costagliola
    • Year: 2023
    • Citations: 5
  • Correlative microscopy (CLEM) of tarsal conjunctival scraping: A new opportunity in the diagnosis of microbial keratitis
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, C. Costagliola
    • Year: 2024
    • Citations: 3
  • Utility of Scanning Electron Microscopy (SEM) for Suspected Microbial Keratoconjunctivitis Unresponsive to Broad-Spectrum Antibiotic Therapy
    • Authors: M. Troisi, S. Del Prete, S. Troisi, M. V. Turco, V. Turco
    • Year: 2023
    • Citations: 3
  • Scanning Electron Microscopy (SEM) Evaluation of the Ultrastructural Effects on Conjunctival Epithelial Cells of a New Multiple-Action Artificial Tear Containing Cross-Linked Hyaluronic Acid
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, M. Rinaldi, C. Costagliola
    • Year: 2024
    • Citations: 2
  • Scanning electron microscopy (SEM) of conjunctival scraping for the diagnosis of atypical cases of Acanthamoeba in culture-negative keratoconjunctivitis
    • Authors: M. Troisi, S. Del Prete, S. Troisi, D. Marasco, C. Costagliola
    • Year: 2024
    • Citations: 2
  • Compatibility of a New Ocular Surface Dye with Disposable and Bi-Weekly Soft Contact Lenses: An Experimental Study
    • Authors: M. Troisi, C. Caruso, L. D’Andrea, M. Rinaldi, R. Piscopo, S. Troisi, …
    • Year: 2024
    • Citations: 2
  • Corneal collagen cross-linking in patients with keratoconus from the Dresden protocol to customized solutions: theoretical basis
    • Authors: C. Caruso, L. D’Andrea, M. Troisi, M. Rinaldi, R. Piscopo, S. Troisi, …
    • Year: 2024
    • Citations: 2

Awards and Presentations🏅

Dr. Troisi has delivered over 30 presentations at esteemed conferences:

  • “SEM Insights into Ocular Surface and Dry Eye Management” – Finalist, Clinical Case Competition, European Dry Eye Society, 2024.
  • “Pathological Alterations of Microvilli Structure” – Winner of the EVER Scientific Photography Competition, 2024.
  • “The Role of Scanning Electron Microscopy in Acanthamoeba Diagnosis” – ESCRS, 2024.

Conclusion 🌍

Dr. Mario Troisi’s dedication to ophthalmology is evident in his clinical expertise, research contributions, and academic achievements. His innovative approach to ocular surface diseases and commitment to advancing medical knowledge position him as a rising leader in the field.